- Shopping Bag ( 0 items )
From The CriticsReviewer: Hyon Ju Park, MD (Washington University Medical Center)
Description: This book incorporates the latest developments in scleroderma in terms of understanding its pathophysiology and management.
Purpose: The purpose is to provide an ultimate source that integrates historical management, current pathophysiology, and the possible future of better therapy. The purpose is worthy but difficult to do, considering the sheer volume of data currently available.
Audience: The book is written for rheumatologists.
Features: It discusses various criteria for systemic sclerosis, role of antibodies, vasculopathy, capillaroscopy, pulmonary hypertension, renal disease, gastrointestinal diseases, etc. The book is thorough, but so dense with incredible detail that it is a difficult read. I am not sure if this is a shortcoming or not, since the authors may be targeting a specific group of rheumatologists (i.e. those who are interested in scleroderma).
Assessment: This book is well written but, as noted, difficult to read due to its thorough nature.